Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 445

1.

Prevalence and patterns of antifolate and chloroquine drug resistance markers in Plasmodium vivax across Pakistan.

Khattak AA, Venkatesan M, Khatoon L, Ouattara A, Kenefic LJ, Nadeem MF, Nighat F, Malik SA, Plowe CV.

Malar J. 2013 Sep 5;12:310. doi: 10.1186/1475-2875-12-310.

2.

Molecular surveillance of drug-resistant Plasmodium vivax using pvdhfr, pvdhps and pvmdr1 markers in Nouakchott, Mauritania.

Mint Lekweiry K, Ould Mohamed Salem Boukhary A, Gaillard T, Wurtz N, Bogreau H, Hafid JE, Trape JF, Bouchiba H, Ould Ahmedou Salem MS, Pradines B, Rogier C, Basco LK, Briolant S.

J Antimicrob Chemother. 2012 Feb;67(2):367-74. doi: 10.1093/jac/dkr464. Epub 2011 Nov 14.

PMID:
22086859
3.

Molecular surveillance of pvdhfr, pvdhps, and pvmdr-1 mutations in Plasmodium vivax isolates from Yunnan and Anhui provinces of China.

Huang B, Huang S, Su XZ, Tong X, Yan J, Li H, Lu F.

Malar J. 2014 Sep 2;13:346. doi: 10.1186/1475-2875-13-346.

4.

Prevalence of drug resistance associated mutations in Plasmodium vivax against sulphadoxine-pyrimethamine in southern Pakistan.

Raza A, Ghanchi NK, Khan MS, Beg MA.

Malar J. 2013 Jul 26;12:261. doi: 10.1186/1475-2875-12-261.

5.

Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine.

Barnadas C, Tichit M, Bouchier C, Ratsimbasoa A, Randrianasolo L, Raherinjafy R, Jahevitra M, Picot S, Ménard D.

Malar J. 2008 Feb 26;7:35. doi: 10.1186/1475-2875-7-35.

6.

Prevalence of drug resistance-associated gene mutations in Plasmodium vivax in Central China.

Lu F, Wang B, Cao J, Sattabongkot J, Zhou H, Zhu G, Kim K, Gao Q, Han ET.

Korean J Parasitol. 2012 Dec;50(4):379-84. doi: 10.3347/kjp.2012.50.4.379. Epub 2012 Nov 26.

7.

Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal.

Ranjitkar S, Schousboe ML, Thomsen TT, Adhikari M, Kapel CM, Bygbjerg IC, Alifrangis M.

Malar J. 2011 Apr 1;10:75. doi: 10.1186/1475-2875-10-75.

8.

Return of chloroquine-sensitive Plasmodium falciparum parasites and emergence of chloroquine-resistant Plasmodium vivax in Ethiopia.

Mekonnen SK, Aseffa A, Berhe N, Teklehaymanot T, Clouse RM, Gebru T, Medhin G, Velavan TP.

Malar J. 2014 Jun 25;13:244. doi: 10.1186/1475-2875-13-244.

9.

Molecular assessment of dhfr/dhps mutations among Plasmodium vivax clinical isolates after introduction of sulfadoxine/pyrimethamine in combination with artesunate in Iran.

Afsharpad M, Zakeri S, Pirahmadi S, Djadid ND.

Infect Genet Evol. 2012 Jan;12(1):38-44. doi: 10.1016/j.meegid.2011.10.003. Epub 2011 Oct 14.

PMID:
22020253
10.

Plasmodium vivax multidrug resistance-1 gene polymorphism in French Guiana.

Faway E, Musset L, Pelleau S, Volney B, Casteras J, Caro V, Menard D, Briolant S, Legrand E.

Malar J. 2016 Nov 8;15(1):540.

11.

A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan.

Khattak AA, Venkatesan M, Jacob CG, Artimovich EM, Nadeem MF, Nighat F, Hombhanje F, Mita T, Malik SA, Plowe CV.

Malar J. 2013 Aug 29;12:300. doi: 10.1186/1475-2875-12-300.

12.

Plasmodium vivax resistance to chloroquine in Madagascar: clinical efficacy and polymorphisms in pvmdr1 and pvcrt-o genes.

Barnadas C, Ratsimbasoa A, Tichit M, Bouchier C, Jahevitra M, Picot S, Ménard D.

Antimicrob Agents Chemother. 2008 Dec;52(12):4233-40. doi: 10.1128/AAC.00578-08. Epub 2008 Sep 22.

13.

Plasmodium vivax in the Democratic Republic of East Timor: Parasite prevalence and antifolate resistance-associated mutations.

de Almeida A, Rosário VE, Henriques G, Arez AP, Cravo P.

Acta Trop. 2010 Sep;115(3):288-92. doi: 10.1016/j.actatropica.2010.04.008. Epub 2010 Apr 20.

PMID:
20412783
14.

Drug resistance associated genetic polymorphisms in Plasmodium falciparum and Plasmodium vivax collected in Honduras, Central America.

Jovel IT, Mejía RE, Banegas E, Piedade R, Alger J, Fontecha G, Ferreira PE, Veiga MI, Enamorado IG, Bjorkman A, Ursing J.

Malar J. 2011 Dec 19;10:376. doi: 10.1186/1475-2875-10-376.

15.

Novel mutations in the antifolate drug resistance marker genes among Plasmodium vivax isolates exhibiting severe manifestations.

Garg S, Saxena V, Lumb V, Pakalapati D, Boopathi PA, Subudhi AK, Chowdhury S, Kochar SK, Kochar DK, Sharma YD, Das A.

Exp Parasitol. 2012 Dec;132(4):410-6. doi: 10.1016/j.exppara.2012.09.018. Epub 2012 Oct 5.

PMID:
23043980
16.

Island-wide diversity in single nucleotide polymorphisms of the Plasmodium vivax dihydrofolate reductase and dihydropteroate synthetase genes in Sri Lanka.

Schousboe ML, Rajakaruna RS, Salanti A, Hapuarachchi HC, Galappaththy GN, Bygbjerg IC, Amerasinghe PH, Konradsen F, Alifrangis M.

Malar J. 2007 Mar 9;6:28.

17.

Plasmodium vivax and Plasmodium falciparum ex vivo susceptibility to anti-malarials and gene characterization in Rondônia, West Amazon, Brazil.

Aguiar AC, Pereira DB, Amaral NS, De Marco L, Krettli AU.

Malar J. 2014 Feb 28;13:73. doi: 10.1186/1475-2875-13-73.

18.

Mutant pfcrt "SVMNT" haplotype and wild type pfmdr1 "N86" are endemic in Plasmodium vivax dominated areas of India under high chloroquine exposure.

Mallick PK, Joshi H, Valecha N, Sharma SK, Eapen A, Bhatt RM, Srivastava HC, Sutton PL, Dash AP, Bhasin VK.

Malar J. 2012 Jan 11;11:16. doi: 10.1186/1475-2875-11-16.

19.

Sequence analysis of genes associated with resistance to chloroquine and sulphadoxine pyrimethamine in P. falciparum and P. vivax isolates from the Bannu district of Pakistan.

Khatoon L, Baliraine FN, Malik SA, Yan G.

Braz J Infect Dis. 2013 Sep-Oct;17(5):596-600. doi: 10.1016/j.bjid.2013.02.005. Epub 2013 Jul 11.

Supplemental Content

Support Center